The Beginning of a long journey ("If Winter Comes" No. 1)
It started with Misdiagnosis #1. His sinuses were hurting him. it was just a sinus problem. A doctor prescribed him antibiotics (Cefnidir).
Then, he had terrible back pain and trouble sitting down. As the weeks passed, he continued to feel worse.
Following a bout with the chills, his fever spiked at 104, so we went to the ER.
- Chest X-ray—OK
White blood cell count—low
Discharged, they tell him to follow up with an infectious disease doctor, Misdiagnosis #2, that doctor thinks it's Viral Meningitis.
The fevers and the pain continue. Then one morning he wakes up with severe chest pains, unable to take a deep breath. Lots more tests, some new drugs including Tylenol and then steroids. Misdiagnosis #3: Lyme disease.
But then one morning, about six weeks after this started, he awoke with pain in the back of his head, its like a lump that feels like the bone and its bigger on the left hand side. Very sore to touch. To the ER and an internist, and then LOTS more tests.
After two days of tests, they did a bone marrow biopsy, and that's where we are right now, awaiting those results …
"If Winter Comes," A blog about anaplastic large cell lymphoma"
This blog follows the journey undertaken by my husband, by me and by our family as my husband battles a disease we never saw coming: He was diagnosed with a rare subtype of T-cell non-Hodgkin's lymphoma known as Anaplastic Large Cell Lymphoma (ALK+) at the age of 32.
Photo by John Nyboer
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
